EIGR Stock Price, News & Analysis

EIGR NASDAQ

Company Description

EIGR (NASDAQ: EIGR) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

EIGR stock has declined 59.7% over the past year.

This page provides a comprehensive overview of EIGR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-59.69%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

EIGR (EIGR) stock. Over the past 12 months, the stock has lost 59.7%.

Latest News

View All

April 1, 2024

-72.23%

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

January 18, 2024

-3.58%

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

January 4, 2024

-6.58%

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split

stock split

November 13, 2023

+2.05%

Cutera Appoints Stephana Patton as Chief Legal Officer

management

November 9, 2023

-11.64%

Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

earnings

September 12, 2023

-40.58%

Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta

clinical trial

EIGR has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 9 with negative movement. Key topics include stock split, management, earnings, clinical trial, conferences. View all EIGR news →

SEC Filings

View All

No SEC filings available for EIGR.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

EIGR Company Profile & Sector Positioning

EIGR (EIGR) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.